Modified annexin proteins and methods for preventing thrombosis

Details for Australian Patent Application No. 2005221195 (hide)

Owner Alavita Pharmaceuticals, Inc.

Inventors Allison, Anthony

Agent Davies Collison Cave

Pub. Number AU-B-2005221195

PCT Pub. Number WO2005/086955

Priority 60/552,428 11.03.04 US; 60/579,589 14.06.04 US

Filing date 10 March 2005

Wipo publication date 22 September 2005

Acceptance publication date 19 May 2011

International Classifications

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

Event Publications

5 October 2006 PCT application entered the National Phase

  PCT publication WO2005/086955 Priority application(s): WO2005/086955

19 May 2011 Assignment before Grant

  Alavita, Inc. The application has been assigned to Alavita Pharmaceuticals, Inc.

19 May 2011 Application Accepted

  Published as AU-B-2005221195

15 September 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005221198-Tailgate counterbalancing hinge

2005221187-Method for inhibiting immune complex formation in a subjetc